Evan Hersh
12Patents
6h-index
26Co-inventors
66Inventor score
Filing activity: Apr 16, 1984 → Dec 12, 2003
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5055289A | Interferon antibody therapeutic compositions having an extended serum half-life | Human Necessities | 39 | Expired |
| US4663167A | Composition and method for treatment of disseminated fungal infections in mammals | Emerging Cross-Sectional Technologies | 37 | Expired |
| US5445960A | Monoclonal antibodies specific for HIV and hybridomas for their production | Human Necessities | 13 | Expired |
| US4978654A | Composition and method for treatment of disseminated fungal infections in mammals | Human Necessities | 12 | Expired |
| US5298419A | Human hybridomas and monoclonal antibodies which bind both gp41 and gp120 envelope proteins of human immunodeficiency virus | Human Necessities | 7 | Expired |
| US5695927A | Monoclonal antibodies specific for HIV and the hybridomas for production thereof | Human Necessities | 7 | Expired |
| US5783670A | Monoclonal antibodies specific for HIV and the hybridomas for production thereof | Human Necessities | 3 | Expired |
| US6709858B1 | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof | Chemistry; Metallurgy | 1 | Expired |
| US7285542B2 | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof | Chemistry; Metallurgy | 0 | Expired |
| US7056897B2 | Inducible expression vectors and methods of use thereof | Chemistry; Metallurgy | 0 | Expired |
| US6297230A | Cyanoaziridines for treating cancer | Chemistry; Metallurgy | 0 | Expired |
| US7098191B2 | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.